Healthcare · Industry
Drug Manufacturers - General - List & Prices (21 stocks)
All 21 Drug Manufacturers - General stocks listed, ranked by market capitalization — 1 page(s), 50 per page.
What Are the Leading Drug Manufacturers - General Stocks?
Prices: Oct 21, 2026 close Last Updated: Oct 21, 2026There are 21 publicly traded Drug Manufacturers - General stocks. The largest by market capitalization are LLY, JNJ, ABBV, MRK, NVS, AZN, AMGN, GILD, NVO, PFE.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Eli Lilly and Company | LLY | $1,270.75 | $1.13T | 42.7 | 0.54% |
| Johnson & Johnson | JNJ | $257.78 | $621.22B | 39.1 | 2.07% |
| AbbVie Inc. | ABBV | $284.80 | $503.27B | 80.5 | 2.39% |
| Merck & Co., Inc. | MRK | $149.88 | $369.78B | 119.0 | 2.29% |
| Novartis AG | NVS | $153.93 | $292.58B | 23.3 | 3.09% |
| AstraZeneca PLC | AZN | $168.45 | $261.82B | 25.2 | 1.95% |
| Amgen Inc. | AMGN | $438.34 | $236.98B | 27.2 | 2.30% |
| Gilead Sciences, Inc. | GILD | $153.57 | $190.42B | 2.10% | |
| Novo Nordisk A/S | NVO | $39.06 | $172.38B | 9.6 | 4.57% |
| Pfizer Inc. | PFE | $29.85 | $170.14B | 39.3 | 5.71% |
| Bristol-Myers Squibb Company | BMY | $61.12 | $124.85B | 13.5 | 4.09% |
| GSK plc | GSK | $50.02 | $100.22B | 15.8 | 3.59% |
| Sanofi | SNY | $40.97 | $98.17B | 21.6 | 5.84% |
| Biogen Inc. | BIIB | $240.98 | $34.50B | 41.5 | — |
| Grifols, S.A. | GRFS | $7.50 | $5.10B | 9.7 | 1.41% |
| Organon & Co. | OGN | $13.75 | $3.61B | 17.6 | 0.58% |
| Amarin Corporation plc | AMRN | $11.51 | $243.12M | — | |
| Nasus Pharma Ltd. | NSRX | $3.06 | $35.84M | — | |
| MIRA Pharmaceuticals, Inc. | MIRA | $0.68 | $28.65M | — | |
| Scilex Holding Company | SCLX | $2.56 | $18.01M | — | |
| Medicus Pharma Ltd. | MDCX | $2.68 | $3.84M | — |
Eli Lilly and Company
Healthcare / Drug Manufacturers - General
- Market Cap
- $1.13T
- P/E
- 42.7
- Dividend Yield
- 0.54%
Johnson & Johnson
Healthcare / Drug Manufacturers - General
- Market Cap
- $621.22B
- P/E
- 39.1
- Dividend Yield
- 2.07%
AbbVie Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $503.27B
- P/E
- 80.5
- Dividend Yield
- 2.39%
Merck & Co., Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $369.78B
- P/E
- 119.0
- Dividend Yield
- 2.29%
Novartis AG
Healthcare / Drug Manufacturers - General
- Market Cap
- $292.58B
- P/E
- 23.3
- Dividend Yield
- 3.09%
AstraZeneca PLC
Healthcare / Drug Manufacturers - General
- Market Cap
- $261.82B
- P/E
- 25.2
- Dividend Yield
- 1.95%
Amgen Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $236.98B
- P/E
- 27.2
- Dividend Yield
- 2.30%
Gilead Sciences, Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $190.42B
- P/E
- unprofitable
- Dividend Yield
- 2.10%
Novo Nordisk A/S
Healthcare / Drug Manufacturers - General
- Market Cap
- $172.38B
- P/E
- 9.6
- Dividend Yield
- 4.57%
Pfizer Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $170.14B
- P/E
- 39.3
- Dividend Yield
- 5.71%
Bristol-Myers Squibb Company
Healthcare / Drug Manufacturers - General
- Market Cap
- $124.85B
- P/E
- 13.5
- Dividend Yield
- 4.09%
GSK plc
Healthcare / Drug Manufacturers - General
- Market Cap
- $100.22B
- P/E
- 15.8
- Dividend Yield
- 3.59%
Sanofi
Healthcare / Drug Manufacturers - General
- Market Cap
- $98.17B
- P/E
- 21.6
- Dividend Yield
- 5.84%
Biogen Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $34.50B
- P/E
- 41.5
Grifols, S.A.
Healthcare / Drug Manufacturers - General
- Market Cap
- $5.10B
- P/E
- 9.7
- Dividend Yield
- 1.41%
Organon & Co.
Healthcare / Drug Manufacturers - General
- Market Cap
- $3.61B
- P/E
- 17.6
- Dividend Yield
- 0.58%
Amarin Corporation plc
Healthcare / Drug Manufacturers - General
- Market Cap
- $243.12M
- P/E
- unprofitable
Nasus Pharma Ltd.
Healthcare / Drug Manufacturers - General
- Market Cap
- $35.84M
- P/E
- unprofitable
MIRA Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $28.65M
- P/E
- unprofitable
Scilex Holding Company
Healthcare / Drug Manufacturers - General
- Market Cap
- $18.01M
- P/E
- unprofitable
Medicus Pharma Ltd.
Healthcare / Drug Manufacturers - General
- Market Cap
- $3.84M
- P/E
- unprofitable
Showing 1–21 of 21 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data. Ranked by market capitalization. Prices are the most recent daily close.
Which Drug Manufacturers - General Stocks Are Reasonably Valued?
Prices: Oct 21, 2026 closeAmong the 21 largest Drug Manufacturers - General companies, Novo Nordisk A/S (NVO) trades at the lowest trailing P/E ratio, 9.6. The industry average is 35.0.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Novo Nordisk A/S | NVO | $39.06 | $172.38B | 9.6 | 4.57% |
| Grifols, S.A. | GRFS | $7.50 | $5.10B | 9.7 | 1.41% |
| Bristol-Myers Squibb Company | BMY | $61.12 | $124.85B | 13.5 | 4.09% |
| GSK plc | GSK | $50.02 | $100.22B | 15.8 | 3.59% |
| Organon & Co. | OGN | $13.75 | $3.61B | 17.6 | 0.58% |
Ranked by trailing twelve-month P/E, lowest first. Companies that report no P/E are not listed. Rankings cover the 21 largest Drug Manufacturers - General companies by market capitalization.
Which Drug Manufacturers - General Stocks Pay the Highest Dividends?
Prices: Oct 21, 2026 close15 of the 21 largest Drug Manufacturers - General companies pay a dividend. Sanofi (SNY) has the highest yield at 5.84%.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Sanofi | SNY | $40.97 | $98.17B | 21.6 | 5.84% |
| Pfizer Inc. | PFE | $29.85 | $170.14B | 39.3 | 5.71% |
| Novo Nordisk A/S | NVO | $39.06 | $172.38B | 9.6 | 4.57% |
| Bristol-Myers Squibb Company | BMY | $61.12 | $124.85B | 13.5 | 4.09% |
| GSK plc | GSK | $50.02 | $100.22B | 15.8 | 3.59% |
Ranked by trailing dividend yield, highest first. Companies that pay no dividend are not listed. Rankings cover the 21 largest Drug Manufacturers - General companies by market capitalization.
Key facts
As of October 21, 2026, 21 Drug Manufacturers - General stocks are listed: all 21 on NYSE & NASDAQ.
The largest by market capitalization is Eli Lilly and Company (LLY) at $1.13T.
The median P/E across the Drug Manufacturers - General industry is 25.2.
Drug Manufacturers - General Industry Overview
From the data · Oct 21, 2026The Drug Manufacturers - General industry, part of the Healthcare sector, includes 21 publicly traded companies with a combined market capitalization of $4.32T in US dollars. The industry is led by Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV).
Among the 21 listed Drug Manufacturers - General companies, market capitalizations range from $1.13T (Eli Lilly and Company) down to $3.84M (Medicus Pharma Ltd.), highlighting the wide size disparity across the industry. The average market cap across the industry is $205.65B, reflecting a mix of established large-cap players and smaller growth-oriented companies.
Drug Manufacturers - General Industry Valuation
The Drug Manufacturers - General industry currently trades at an average price-to-earnings (P/E) ratio of 35.0. This elevated multiple indicates that investors are pricing in strong future earnings growth across Drug Manufacturers - General companies.
Drug Manufacturers - General Dividend Profile
15 out of 21 Drug Manufacturers - General companies (71%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Drug Manufacturers - General stocks is 2.83%. The high proportion of dividend payers suggests Drug Manufacturers - General is a mature, cash-generating industry that rewards income-focused investors.
Frequently Asked Questions
What are the leading Drug Manufacturers - General stocks?
The largest Drug Manufacturers - General stocks by market capitalization are Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK), Novartis AG (NVS). All 21 companies are ranked by market cap on this page.
Where can I find a complete list of Drug Manufacturers - General stocks?
This page is the complete list: 21 Drug Manufacturers - General companies across 1 page(s), 50 per page, ranked by market capitalization — including LLY, JNJ, ABBV, MRK, NVS.
How many Drug Manufacturers - General stocks are there?
There are 21 publicly traded Drug Manufacturers - General companies: all 21 on NYSE & NASDAQ. By market capitalization, they range from Eli Lilly and Company (LLY) to Medicus Pharma Ltd. (MDCX). This directory spans 1 pages, with all companies sorted by market cap for easy comparison.
Which Drug Manufacturers - General stocks are reasonably valued?
Among the 21 largest Drug Manufacturers - General companies, Novo Nordisk A/S (NVO) carries the lowest trailing P/E at 9.6, against an industry average of 35.0.
Which Drug Manufacturers - General stocks have the highest dividend yield?
15 of the 21 Drug Manufacturers - General companies (71%) pay a dividend, with an average yield of 2.83% among payers. The highest yield among the 21 largest is Sanofi (SNY) at 5.84%.
Explore Drug Manufacturers - General Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 21 Drug Manufacturers - General companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Drug Manufacturers - General stocks head to head. All data is updated regularly to reflect the latest available financials.